Synergistic Effect of Stromal Vascular Fraction and Lymph Node Transfer in a Rabbit Hindlimb Model
1Department of Plastic and Reconstructive Surgery, Korea University Anam Hospital, 73 Goryeodae-Ro, Seongbuk-Gu, Seoul, 02841, Republic of Korea.
Related Experiment Videos
View abstract on PubMed
Summary
Combining stromal vascular fraction (SVF) with vascularized lymph node transfer (VLNT) in a single stage improves lymph node viability and structural integrity. This approach shows promise for treating advanced lymphedema.
Area of Science:
- Regenerative Medicine
- Vascular Biology
- Lymphedema Treatment
Background:
- Adipose-derived stem cells (ADSCs) promote lymphangiogenesis, but their use with vascularized lymph node transfer (VLNT) is underexplored.
- Stromal vascular fraction (SVF) offers an intraoperative alternative to cultured ADSCs, suitable for single-stage VLNT procedures.
- This study investigates the synergistic effects of combined VLNT and SVF therapy in a rabbit hindlimb lymphedema model.
Purpose of the Study:
- To evaluate the impact of combining SVF therapy with VLNT in a single surgical procedure.
- To assess the therapeutic efficacy of combined VLNT and SVF on lymphedema in a rabbit model.
- To determine the effects on lymph node viability, structural integrity, and molecular markers.
Main Methods:
- New Zealand white rabbits were assigned to control, VLNT only, SVF only, or combined VLNT plus SVF groups.
- VLNT involved transferring a pedicled lymph node flap; SVF was injected into perinodal tissue.
- Assessments included edema volume measurement, ICG lymphography, histology, and VEGF-C/LYVE-1 expression analysis.
Main Results:
- Combined VLNT plus SVF significantly reduced hindlimb edema by week 4 compared to controls.
- Histology revealed superior lymph node structural integrity and reduced fibroadipose tissue in the combined group.
- Elevated VEGF-C was observed in SVF-treated groups, with increased LYVE-1 expression in the combined group by week 8.
Conclusions:
- SVF can be effectively integrated with VLNT in a single-stage procedure, enhancing vascularized lymph node viability.
- The combined approach shows potential for improving structural integrity and therapeutic outcomes in advanced lymphedema.
- Further clinical trials are warranted to explore this promising therapeutic strategy.